Replicel Life Sciences Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021 – amended

ended 12/31/21 FY 2021

Late filing notification for annual report of foreign issuer

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Ownership Filter

Mackay Jamie Myles

Mackay Jamie Myles

News Filter

Announces a Letter of Intent for Asset Purchase Agreement

Condensed Consolidated Interim Financial Statements

Condensed Consolidated Interim Financial Statements

Provides Default Status Update

Provides Default Status Update and Announces Shareholder Approval of Equity Incentive Plan

Proxies

No filings in this category.

Other Filter

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC